Travere Therapeutics (TVTX) PT Raised to $23 at Stifel
Tweet
Share
E-mailGet Alerts TVTX Hot Sheet
Price: $62.14 +1.16%
Rating Summary:
12 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
12 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Stifel analyst Alex Thompson raised the price target on Travere Therapeutics (NASDAQ: TVTX) to $23.00 (from $22.00) while maintaining a Hold rating.
You May Also Be Interested In
- Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Indigo Paints (INDIGOPN:IN) PT Raised to INR1,300 at ICICI Securities
- Chemtrade Logistics Income Fund (CHE-U:CN) (CGIFF) PT Raised to Cdn$18.50 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
